Literature DB >> 16882205

Imatinib mesilate inhibits melanogenesis in vitro.

M Cario-André, L Ardilouze, C Pain, Y Gauthier, F-X Mahon, A Taieb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16882205     DOI： 10.1111/j.1365-2133.2006.07359.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  6 in total

1.  Diffuse hypopigmentation followed by hyperpigmentation in an african american woman with hemangiopericytoma treated with dasatinib.

Authors:  Karim Boudadi; Rashmi Chugh
Journal:  J Clin Diagn Res       Date:  2014-11-20

2.  Imatinib mesylate-induced hyperpigmentation of the nose and palate.

Authors:  Hyo Sang Song; Hee Young Kang
Journal:  Ann Dermatol       Date:  2014-07-31       Impact factor: 1.444

Review 3.  Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis.

Authors:  Julia Dai; Viswanath R Belum; Shenhong Wu; Vincent Sibaud; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2017-09-14       Impact factor: 11.527

4.  Familial gastrointestinal stromal tumors with KIT germline mutation in a Chinese family: A case report.

Authors:  Wei Yuan; Wen Huang; Lei Ren; Chen Xu; Li-Juan Luan; Jie Huang; An-Wei Xue; Yong Fang; Xiao-Dong Gao; Kun-Tang Shen; Jing-Huan Lv; Ying-Yong Hou
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

5.  Disappearing pigmentary mosaicism during imatinib treatment for gastrointestinal stromal tumors.

Authors:  Emily Coleman; Gauri Panse; Shawn Cowper; Jill Lacy; Jonathan Leventhal
Journal:  JAAD Case Rep       Date:  2019-01-30

6.  Asoprisnil, a Selective Progesterone Receptor Modulator (SPRM), Inhibits Melanosome Export in B16F10 Cells and HEMn-DP Melanocytes.

Authors:  Shilpi Goenka; Sanford R Simon
Journal:  Molecules       Date:  2020-08-06       Impact factor: 4.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.